MOHAMMAD JAVED: Open Payments
NPI 1497195481 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 12 payments from 10 companies in 2025. Trend: 2023 $604 · 2024 $299 · 2025 $1,126
Travel & lodging: $899Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $899 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Biogen, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: Deep TMS, Qelbree, VRAYLAR, INGREZZA, ZURZUVAE, Jornay PM, REXULTI, ARISTADA.
Industry payments across TX — which companies pay providers there.
